Atrayee Bhattacharya, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucin-1 | 13 | 2023 | 543 | 1.620 |
Why?
|
Chromatin Assembly and Disassembly | 3 | 2022 | 635 | 0.790 |
Why?
|
NF-kappa B | 1 | 2023 | 2499 | 0.500 |
Why?
|
Neuroendocrine Cells | 2 | 2022 | 61 | 0.400 |
Why?
|
Neoplastic Stem Cells | 4 | 2022 | 1376 | 0.360 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2022 | 8428 | 0.340 |
Why?
|
Neoplastic Processes | 1 | 2023 | 35 | 0.240 |
Why?
|
Interferon-gamma | 2 | 2022 | 3206 | 0.220 |
Why?
|
Transcription Factor AP-1 | 1 | 2023 | 317 | 0.210 |
Why?
|
Acrylamides | 1 | 2023 | 255 | 0.200 |
Why?
|
Neoplasms | 3 | 2023 | 21683 | 0.180 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 736 | 0.170 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2022 | 300 | 0.160 |
Why?
|
Exosomes | 1 | 2023 | 417 | 0.160 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2022 | 388 | 0.150 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 332 | 0.140 |
Why?
|
Chromatin | 3 | 2023 | 2934 | 0.140 |
Why?
|
Oncogenes | 1 | 2022 | 1265 | 0.140 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2187 | 0.130 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3647 | 0.130 |
Why?
|
Transcription Factors | 4 | 2023 | 12208 | 0.130 |
Why?
|
Indoles | 1 | 2023 | 1839 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5221 | 0.120 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1119 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2915 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.110 |
Why?
|
Pyrimidines | 1 | 2023 | 2942 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1634 | 0.090 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13102 | 0.080 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11124 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9438 | 0.080 |
Why?
|
Cell Line, Tumor | 4 | 2023 | 16689 | 0.070 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3586 | 0.070 |
Why?
|
Signal Transduction | 6 | 2023 | 23403 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6364 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5256 | 0.060 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6773 | 0.060 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2023 | 91 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5686 | 0.050 |
Why?
|
Receptors, Interferon | 1 | 2022 | 115 | 0.050 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2021 | 68 | 0.050 |
Why?
|
Humans | 13 | 2023 | 744343 | 0.050 |
Why?
|
STAT1 Transcription Factor | 1 | 2021 | 320 | 0.040 |
Why?
|
Interferons | 1 | 2023 | 706 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2023 | 986 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2022 | 749 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5535 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1366 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2020 | 1730 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3282 | 0.030 |
Why?
|
DNA Helicases | 1 | 2020 | 859 | 0.030 |
Why?
|
Mice, Nude | 1 | 2022 | 3689 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1660 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2023 | 2503 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9648 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
DNA Damage | 1 | 2023 | 2432 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6314 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.030 |
Why?
|
Male | 4 | 2022 | 350118 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2020 | 4204 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2022 | 4803 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3086 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3597 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5867 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9386 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5172 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 29786 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7301 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15997 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5853 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9583 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12072 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81183 | 0.010 |
Why?
|
Female | 2 | 2022 | 380194 | 0.010 |
Why?
|
Animals | 1 | 2022 | 168757 | 0.010 |
Why?
|